Cite

    Michelle Petri et al.. “Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports.” Annals of the rheumatic diseases, vol. 82, no. 2, 2023, pp. 217–225. http://access.bl.uk/ark:/81055/vdc_100174257022.0x000064